• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Tela Bio touts data for OviTex hernia repair bioscaffold

Tela Bio touts data for OviTex hernia repair bioscaffold

June 6, 2017 By Sarah Faulkner

Tela BioTela Bio touted data this week for its OviTex reinforced bioscaffold used for hernia repair and abdominal wall reconstruction.

The device combines biologic material and polymer, allowing for free movement of fluid and cells through the mesh. Tela Bio’s chief medical officer is slated to present initial feedback from surgeons using the device since it won FDA 510(k) clearance in June last year.

Surgeons observed 134 patients treated with OviTex and provided feedback for 128 patients after 108 days of follow-up, on average. The company reported that the surgeons did not observe any device failures or hernia recurrences.

“OviTex RBSs have now been successfully used in a wide range of hernia repair procedures,” Dr. Maarten Persenaire said in prepared remarks. “Surgeons are noting that OviTex RBSs are easy to handle, trim, suture, and tack in all surgical approaches, and conform well to contours of surgical sites. We are also encouraged by surgeon reports of reduced volume and duration of drainage post-operatively. This gives us confidence for our prospective multi-center ventral hernia Bravo study which started enrollment this April.”

In a separate presentation, chief technology officer Skott Greenhalgh and hernia surgeon Dr. Stephen Ferzoco touted data from a preclinical study assessing the permeability of various hernia repair materials, including OviTex RBSs.

The study showed that the company’s mesh exhibited permeability, which stood in contrast to market-leading biologic materials and coated synthetic meshes, according to Tela Bio.

“Little attention has been paid to the permeability of hernia repair materials and the role permeability plays in their clinical performance,” Greenhalgh said. “We believe it is important that OviTex RBSs exhibit permeability, as this may reduce the incidence of post-operative complications, including seromas. Furthermore, permeable implants could enhance tissue integration and remodeling through free movement of fluid and cells, which are critical to long-term durability of the repair.”

Filed Under: Clinical Trials, Materials Testing, Regenerative Medicine Tagged With: Tela Bio

More recent news

  • Penumbra completes enrollment in pulmonary embolism trial
  • Zoll opens new facility in Rhode Island
  • FDA expands clearance for Inquis Medical’s Aventus thrombectomy system
  • SS Innovations completes first robotic cardiac surgery in the Americas
  • GI Windows wins FDA nod for magnet tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy